Mature results from EV-101: A phase I study of enfortumab vedotin in patients with metastatic urothelial cancer (mUC) Meeting Abstract


Authors: Rosenberg, J. E.; Sridhar, S. S.; Zhang, J.; Smith, D. C.; Ruether, J. D.; Flaig, T. W.; Baranda, J. C.; Lang, J. M.; Plimack, E. R.; Sangha, R. S.; Heath, E. I.; Merchan, J. R.; Quinn, D. I.; Srinivas, S.; Milowsky, M. I.; Wu, C.; Gartner, E. M.; Melhem-Bertrandt, A.; Petrylak, D. P.
Abstract Title: Mature results from EV-101: A phase I study of enfortumab vedotin in patients with metastatic urothelial cancer (mUC)
Meeting Title: 2019 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 7 Suppl.
Meeting Dates: 2019 Feb 14-16
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-03-01
Language: English
ACCESSION: WOS:000489108800394
DOI: 10.1200/JCO.2019.37.7_suppl.377
PROVIDER: wos
Notes: Meeting Abstract: 377 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg